Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Earnings Release 2017

Nov 22, 2017

6785_rns_2017-11-22_f5e82cd0-724a-4e1e-b1a0-d58b6f34eb1f.htm

Earnings Release

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 380
EVOGENE LTD
Corporation no: 512838723 10571
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 22/11/2017
www.isa.gov.il www.tase.co.il Reference: 2017-02-103054 Time of broadcast: 13:54 13:34:43

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress Release: Evogene Reports Third Quarter 2017 Financial Results

2017_Q3_FS_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 06/11/2017
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: [email protected] 1